BP
LLY icon

BNP Paribas’s Eli Lilly LLY Stock Holding History

BNP Paribas’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.6M Sell
36,643
-605
-2% -$613K 1.07% 23
2025
Q4 		$40M Buy
37,248
+718
+2% +$687K 1.15% 21
2025
Q3 		$27.9M Sell
36,530
-109
-0.3% -$81.1K 0.84% 31
2025
Q2 		$28.5M Buy
36,639
+164
+0.4% +$127K 0.93% 30
2025
Q1 		$31.3M Buy
36,475
+1,847
+5% +$1.54M 1.3% 20
2024
Q4 		$26.7M Sell
34,628
-5,892
-15% -$4.88M 0.16% 30
2024
Q3 		$35.8M Buy
40,520
+11,327
+39% +$10.2M 1.49% 19
2024
Q2 		$26.4M Buy
29,193
+2,971
+11% +$2.38M 1.33% 23
2024
Q1 		$20.4M Buy
+26,222
New +$18.7M 0.95% 30

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BNP Paribas's LLY Position: Q1 2026 in Review

BNP Paribas reduced its Eli Lilly (LLY) stake by 1.6% in Q1 2026, selling an estimated $613K and leaving 36,643 shares worth $33.6M. The position accounts for 1.07% of the portfolio, ranked #23.

BNP Paribas first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $40M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • BNP Paribas held 36,643 shares of Eli Lilly worth $33.6M as of Q1 2026.
  • BNP Paribas sold 605 Eli Lilly shares in Q1 2026, an estimated $613K.
  • Eli Lilly made up 1.07% of BNP Paribas's portfolio in Q1 2026, its #23 holding.
  • BNP Paribas first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
  • BNP Paribas's Eli Lilly position peaked at $40M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on BNP Paribas's 13F filing for Q1 2026, filed 12 May 2026.